Pharma Marketing News is the monthly newsletter of the Pharma Marketing Network. It is distributed FREE to registered subscribers via email and the Web.
Editorial & Advisory Board
We accept advertising relevant to the interests of our subscribers.
For more information, see:
Published by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
Pharma Marketing News |
Subscribe |
Discussion Forums |
Roundtable |
Podcasts |
Blog
Daily News Briefs |
Surveys |
Resources/Links |
Glossary |
Case Studies |
Reports
Pharma Marketing Vendor Directory |
Conference Calendar |
Pharma Jobs
Advertising Information |
FAQs |
About Us |
Privacy Policy
I am pleased to offer the following third-party reports selected on the basis of their relevance to the interests of pharmaceutical marketing professionals.
John Mack, Publisher and Editor
Pharma Marketing News
| Aspects of Medical Science Liaison Compliance and Activity-Auditing |
Regulatory scrutiny has focused on the direct- and indirect drivers on MSLs' activities. Therefore, companies should realize that the symbol (what function the MSL program reports to, what advanced degrees MSLs hold) does not matter as much as the substance (what MSLs are actually expected to do, who applies the greatest pressures on MSL objectives) when it comes to evaluating activity drivers. It now looks like the golden age of regulating industry's conduct is upon Pharma.. Order this article and learn more ...Order and pay for this reprint now using your credit card... ONLY $29.95
Download PDF file immediately after paying:
| Medical Science Liaisons: Biotech's Special Forces |
Biotechnology companies with a product commercialization strategy are deploying field-based medical science liaisons (MSLs) to increase awareness of a therapeutic market, support clinical trials, and educate the healthcare community on appropriate product utilization. Attracting experienced MSLs to smaller or younger companies remains a significant challenge for MSL directors. This article provides helpful suggestions that biotech and other science-based companies can use to build their MSL force. Order this article and learn more ...Order and pay for this reprint now using your credit card... ONLY $24.95
Download PDF file immediately after paying:
| Medical Science Liaison Roles: Enigma and Dilemma |
After many hundreds of millions of penalty dollars from questionable sales and marketing practices, are pharmaceutical companies finally doing the "right" thing, at least where MSL roles are concerned? Are MSL directors trying? And are they getting more support from upper management? Order this article and learn more ...Order and pay for this reprint now using your credit card... ONLY $29.95
Download PDF file immediately after paying:
| MSL Training Design with ROI in Mind |
If we define Medical Science Liaison (MSL) training as enabling an MSL to adopt a desired behavior or fulfill a desired performance expectation, we can readily see how most of what we call "training" is not really training at all. Most MSL training involves information sessions where we try to dump as much information on the MSL as we can in a given time period. The agenda can look impressive and the slide decks even more so, but when the MSL leaves the training, what behaviors and performance are shown as a result of the two or three days you and the MSL have just invested? In other words, what kind of ROI can you expect from MSL training?Order and pay for this reprint now using your credit card... ONLY $29.95
Download PDF file immediately after paying:
| Off-Label Information Dissemination, Safe Harbor, and MSLs |
This article discusses the often misinterpreted "safe harbor" and whether MSLs enjoy such protection when disseminating off-label information. Where, if anywhere, does the law ascribe "safe harbor" surrounding verbal and written dissemination of off-label use for a drug? Ironically, the term "safe harbor" is not found in FDAMA document. If a pharmaceutical employee works within the boundaries specified by what is collectively identified as "safe harbor," the company is safe. If the employee's actions fall outside the box, it is fair game. This does not mean it is illegal per se. Order this article and learn more ...Order and pay for this reprint now using your credit card... ONLY $24.95
Download PDF file immediately after paying:
| Subscribe |
|
A FREE monthly e-newsletter for pharma marketing professionals. Current Issue Order Reprints
|
| Find a Vendor |
|
Hundreds of pharmaceutical marketing services vendors, consultants, executive search firms, medical education companies, and other companies servicing the needs of the pharmaceutical industry. Learn More Access Listings
|
| Network |
|
Network with your peers in the industry, seek help advancing your career, discuss current issues. Learn More
|
| Advertise |
|
Pharma Marketing Network & Pharma Marketing News provide exceptional permission-based e-marketing opportunities. Learn More Media Kit Get Rate Card Click Here
|
| Meet |
|
Pharma Marketing News is proud to be a media partner for dozens of industry conferences. Conference Calendar Get Your Event Listed Click Here
|
| Find a Job |
|
Pharma Marketing Network accepts job listings relevant to the interests of our members and its members help colleagues find jobs. Job Listings Post Your Job Opening Click Here
|